Serum hepatic enzyme activity and alcohol drinking status in relation to the prevalence of metabolic syndrome in the general Japanese population

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Uemura, Hirokazu ^a   Katsuura Kamano, Sakurako ^a   Yamaguchi, Miwa ^a   Sawachika, Fusakazu ^a   Arisawa, Kokichi ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRINKING BEHAVIOR; ENZYME ACTIVITY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PATHOLOGY; POPULATION RESEARCH; PREVALENCE; SEX RATIO; BLOOD; CROSS-SECTIONAL STUDY; ENZYMOLOGY; EPIDEMIOLOGY; JAPAN; LIVER; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ALANINE TRANSAMINASE; ALCOHOL DRINKING; CROSS-SECTIONAL STUDIES; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; JAPAN; LIVER; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; YOUNG ADULT;

EID: 84899673057     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0095981     Document Type: Article

References (35)

1. Flegal KM, Carroll MD, Ogden CL, Johnson CL (2002) Prevalence and trends in obesity among US adults, 1999-2000. JAMA 288: 1723-1727.
2. Ford ES (2005) Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 28: 2745-2749.
3. Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM (2003) The metabolic syndrome as predictor of type 2 diabetes: the San Antonio Heart Study. Diabetes Care 26: 3153-3159. (Pubitemid 37339513)
4. Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DS, et al. (2003) Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 108: 414-419. (Pubitemid 36935533)
5. McNeill AM, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, et al. (2005) The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 28: 385-390. (Pubitemid 40170944)
6. Lee DS, Evans JC, Robins SJ, Wilson PW, Albano I, et al. (2007) Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 27: 127-133. (Pubitemid 46360389)
7. Lee MY, Koh SB, Koh JH, Nam SM, Shin JY, et al. (2008) Relationship between gamma-glutamyltransferase and metabolic syndrome in a Korean population. Diabet Med 25: 469-475. (Pubitemid 351490125)
8. Hsu CH, Wang JY, Chen YL, Liu CC, Chang YL, et al. (2011) Relationships between alanine aminotransferase levels, abnormal liver echogenicity, and metabolic syndrome. J Am Board Fam Med 24: 407-414.
9. Uemura H, Arisawa K, Hiyoshi M, Kitayama A, Takami H, et al. (2009) Prevalence of metabolic syndrome associated with body burden levels of dioxin and related compounds among Japan's general population. Environ Health Perspect 117: 568-573.
10. Nakamoto M, Arisawa K, Uemura H, Katsuura S, Takami H, et al. (2013) Association between blood levels of PCDDs/PCDFs/dioxin-like PCBs and history of allergic and other diseases in the Japanese population. Int Arch Occup Environ Health 86: 849-859.
11. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, et al. (2005) American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112: 2735-2752. (Pubitemid 41532612)
12. Lauria MW, Moreira LM, Machado-Coelho GL, Neto RM, Soares MM, et al. (2013) Ability of body mass index to predict abnormal waist circumference: receiving operating characteristics analysis. Diabetol Metab Syndr 5(1): 74.
13. Kashiwagi A, Kasuga M, Araki E, Oka Y, Hanafusa T, et al. (2012) Committee on the Standardization of Diabetes Mellitus-Related Laboratory Testing of Japan Diabetes Society. International Clinical Harmonization of Glycated Hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program Values. J Diabetes Invest 3: 39-40.
14. Meisinger C, Doring A, Schneider A, Lowel H (2006) Serum gammaglutamyltransferase is a predictor of incident coronary events in apparently healthy men from the general population. Atherosclerosis 189: 297-302. (Pubitemid 44637220)
15. Lee DS, Evans JC, Robins SJ, Wilson PW, Albano I, et al. (2007) Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 27: 127-133. (Pubitemid 46360389)
16. Schindhelm RK, Dekker JM, Nijpels G, Bouter LM, Stehouwer CD, et al. (2007) Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study. Atherosclerosis 191: 391-396. (Pubitemid 46400701)
17. Nakanishi N, Suzuki K, Tatara K (2003) Clustered features of the metabolic syndrome and the risk for increased aortic pulse wave velocity in middle-aged Japanese men. Angiology 54: 551-559. (Pubitemid 37175531)
18. McCullough AJ (2004) The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clin Liver Dis 8: 521-533, viii.
19. Hossain N, Afendy A, Stepanova M, Nader F, Srishord M, et al. (2009) Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 7: 1224-1229.
20. Angelico F, Del Ben M, Conti R, Francioso S, Feole K, et al. (2003) Nonalcoholic fatty liver syndrome: a hepatic consequence of common metabolic diseases. J Gastroenterol Hepatol 18: 588-594. (Pubitemid 36645294)
21. Clark JM, Brancati FL, Diehl AM (2003) The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 98: 960-967. (Pubitemid 36733754)
22. Westerbacka J, Cornér A, Tiikkainen M, Tamminen M, Vehkavaara S, et al. (2004) Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk. Diabetologia 47: 1360-1369. (Pubitemid 39232420)
23. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, et al. (2001) Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50: 1844-1850. (Pubitemid 33641605)
24. Angelico F, Del Ben M, Conti R, Francioso S, Feole K, et al. (2005) Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease. J Clin Endocrinol Metab 90: 1578-1582. (Pubitemid 40464021)
25. Whitefield JB (2002) Gamma glutamyl transferase. Crit Rev Clin Lab Sci 38: 263-355.
26. Tahan V, Canbakan B, Balci H, Dane F, Akin H, et al. (2008) Serum gammaglutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk. Hepatogastroenterology 55: 1433-1438.
27. Li M, Campbell S, McDermott R (2009) gamma-Glutamyltransferase, obesity, physical activity, and the metabolic syndrome in indigenous Australian adults. Obesity (Silver Spring) 17: 809-813.
28. Lee HD, Jacobs DR Jr (2005) Association between serum gamma-glutamyltransferase and C-reactive protein. Atherosclerosis 178: 327-330.
29. Dong MH, Bettencourt R, Barrett-Connor E, Loomba R (2010) Alanine aminotransferase decreases with age: the Rancho Bernardo Study. PLoS One 5(12): e14254. doi: 10.1371/journal.pone.0014254.
30. Prati D, Taioli E, Zanella A, Della Torre E, Butelli S, et al. (2002) Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 137: 1-10.
31. Cushman P, Jacobson G, Barboriak JJ, Anderson AJ (1984) Biochemical markers for alcoholism: sensitivity problems. Alcohol Clin Exp Res 8: 253-257. (Pubitemid 14081330)
32. Alkerwi A, Boutsen M, Vaillant M, Barre J, Lair ML, et al. (2009) Alcohol consumption and the prevalence of metabolic syndrome: a meta-analysis of observational studies. Atherosclerosis 204: 624-635.
33. Stoutenberg M, Lee DC, Sui X, Hooker S, Horigian V, et al. (2013) Prospective study of alcohol consumption and the incidence of the metabolic syndrome in US men. Br J Nutr 23: 1-10.
34. Kim BJ, Kim BS, Kang JH (2012) Alcohol consumption and incidence of metabolic syndrome in korean men. A 3-year follow-up study. Circ J 76: 2363-2371.
35. Kim MY, Kim SS, Kim JS, Jung JG, Kwon BR, et al. (2012) Relationship between Alcohol Consumption and Metabolic Syndrome according to Facial Flushing in Korean Males. Korean J Fam Med 33: 211-218.